| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 28.10B | 27.57B | 26.32B | 26.17B | 20.23B | 19.23B |
| Gross Profit | 5.65B | 5.42B | 5.17B | 4.89B | 3.37B | 3.52B |
| EBITDA | 3.42B | 3.34B | 3.26B | 3.19B | 1.90B | 2.25B |
| Net Income | 1.45B | 1.51B | 1.77B | 1.30B | 521.26M | 288.41M |
Balance Sheet | ||||||
| Total Assets | 30.89B | 31.03B | 29.48B | 25.94B | 24.57B | 23.14B |
| Cash, Cash Equivalents and Short-Term Investments | 9.91B | 10.37B | 10.26B | 8.76B | 7.97B | 8.11B |
| Total Debt | 6.98B | 6.95B | 5.40B | 5.00B | 5.40B | 6.21B |
| Total Liabilities | 12.24B | 11.72B | 10.57B | 9.72B | 10.17B | 10.39B |
| Stockholders Equity | 17.71B | 18.37B | 17.96B | 15.34B | 13.60B | 12.01B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -388.72M | 1.09B | 1.23B | 109.58M | 1.09B |
| Operating Cash Flow | 0.00 | 2.27B | 3.86B | 2.59B | 1.43B | 1.99B |
| Investing Cash Flow | 0.00 | -2.50B | -4.00B | -918.48M | -1.23B | -1.59B |
| Financing Cash Flow | 0.00 | 379.51M | -237.03M | -746.61M | -1.04B | -175.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥13.44B | 9.83 | ― | 2.77% | 3.32% | 63.26% | |
80 Outperform | ¥46.23B | 7.34 | ― | 3.21% | 7.99% | 50.13% | |
79 Outperform | ¥101.26B | 15.13 | ― | 3.23% | 7.28% | 4.16% | |
78 Outperform | ¥15.40B | 6.19 | ― | 5.18% | 4.04% | 12.46% | |
73 Outperform | ¥19.30B | 18.81 | ― | 2.93% | -1.58% | 12.24% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥9.23B | 16.72 | ― | 2.45% | 15.66% | -69.17% |